Clinical Pharmacology Details


TELBIVUDINE


View Drug Forms

Indications & Dose:

Chronic hepatitis B infection with compensated liver disease, evidence of viral replication, and histologically documented active liver inflammation or fibrosis.   



ADULT and CHILD Over 16 years, 600mg once daily

Contraindications:

 breast-feeding 

Side Effects:

nausea, diarrhoea, abdominal pain, raised serum amylase and lipase; cough; dizziness, headache, fatigue; rash; less commonly arthralgia, myalgia, and rnyopathy 

Cautions:

monitor liver function tests every 3 months and viral and serological markers of hepatitis B every 3—6 months; discontinue if deterioration in liver function, hepatic steatosis, progressive hepatomegaly or unexplained lactic acidosis; recurrent hepatitis may occur on discontinuation;renal impairment ; pregnancy


COUNSELLING: Patients should be advised to promptly report unexplained muscle pain, tenderness or weakness 

Precautions:

Interaction:

Warnings:

Adverse Effects:

Lactations:

Special Precautions:

Counselling:

Side Effects Or Adverse Reactions:

Patient And Carer Advice: